Annual Current Liabilities
$23.91 M
-$9.22 M-27.84%
December 31, 2023
Summary
- As of February 8, 2025, ALGS annual total current liabilities is $23.91 million, with the most recent change of -$9.22 million (-27.84%) on December 31, 2023.
- During the last 3 years, ALGS annual current liabilities has fallen by -$6.37 million (-21.03%).
- ALGS annual current liabilities is now -38.63% below its all-time high of $38.96 million, reached on December 31, 2021.
Performance
ALGS Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$20.96 M
-$2.61 M-11.07%
September 30, 2024
Summary
- As of February 8, 2025, ALGS quarterly total current liabilities is $20.96 million, with the most recent change of -$2.61 million (-11.07%) on September 30, 2024.
- Over the past year, ALGS quarterly current liabilities has dropped by -$2.95 million (-12.34%).
- ALGS quarterly current liabilities is now -49.33% below its all-time high of $41.36 million, reached on March 31, 2022.
Performance
ALGS Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
ALGS Current Liabilities Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | -27.8% | -12.3% |
3 y3 years | -21.0% | -25.4% |
5 y5 years | +219.2% | -25.4% |
ALGS Current Liabilities Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3-year | -38.6% | at low | -49.3% | +11.0% |
5 y | 5-year | -38.6% | +73.0% | -49.3% | +51.7% |
alltime | all time | -38.6% | +219.2% | -49.3% | +51.7% |
Aligos Therapeutics Current Liabilities History
Date | Annual | Quarterly |
---|---|---|
Sep 2024 | - | $20.96 M(-11.1%) |
Jun 2024 | - | $23.56 M(+24.8%) |
Mar 2024 | - | $18.88 M(-21.0%) |
Dec 2023 | $23.91 M(-27.8%) | $23.91 M(+6.4%) |
Sep 2023 | - | $22.47 M(-17.5%) |
Jun 2023 | - | $27.23 M(-3.0%) |
Mar 2023 | - | $28.08 M(-15.2%) |
Dec 2022 | $33.13 M | $33.13 M(+8.5%) |
Sep 2022 | - | $30.54 M(-3.5%) |
Jun 2022 | - | $31.65 M(-23.5%) |
Date | Annual | Quarterly |
---|---|---|
Mar 2022 | - | $41.36 M(+6.2%) |
Dec 2021 | $38.96 M(+28.7%) | $38.96 M(+12.0%) |
Sep 2021 | - | $34.78 M(+15.6%) |
Jun 2021 | - | $30.10 M(+19.3%) |
Mar 2021 | - | $25.23 M(-16.7%) |
Dec 2020 | $30.27 M(+119.1%) | $30.27 M(+51.5%) |
Sep 2020 | - | $19.98 M(+30.1%) |
Jun 2020 | - | $15.36 M(+11.2%) |
Dec 2019 | $13.82 M(+84.5%) | $13.82 M |
Dec 2018 | $7.49 M | - |
FAQ
- What is Aligos Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Aligos Therapeutics?
- What is Aligos Therapeutics annual current liabilities year-on-year change?
- What is Aligos Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Aligos Therapeutics?
- What is Aligos Therapeutics quarterly current liabilities year-on-year change?
What is Aligos Therapeutics annual total current liabilities?
The current annual current liabilities of ALGS is $23.91 M
What is the all time high annual current liabilities for Aligos Therapeutics?
Aligos Therapeutics all-time high annual total current liabilities is $38.96 M
What is Aligos Therapeutics annual current liabilities year-on-year change?
Over the past year, ALGS annual total current liabilities has changed by -$9.22 M (-27.84%)
What is Aligos Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of ALGS is $20.96 M
What is the all time high quarterly current liabilities for Aligos Therapeutics?
Aligos Therapeutics all-time high quarterly total current liabilities is $41.36 M
What is Aligos Therapeutics quarterly current liabilities year-on-year change?
Over the past year, ALGS quarterly total current liabilities has changed by -$2.95 M (-12.34%)